August 26, 2024
The US Food and Drug Administration (FDA) has cleared the Omnipod 5 for use by people aged 18 and older with type 2 diabetes, a first […]
August 26, 2024
The first — but not the last — over-the-counter continuous glucose monitor (CGM) is now available for people older than 18 years who don’t use insulin […]
August 26, 2024
TOPLINE: Although the 2015 American Thyroid Association (ATA) guidelines led to an increase in thyroid lobectomies being performed, it did not result in high rates of […]
August 23, 2024
“Moon face” is a term that’s become popular on social media, used to describe people with unusually round faces who are purported to have high levels […]
August 23, 2024
TOPLINE: Women with polycystic ovary syndrome (PCOS) face an increased risk for type 2 diabetes (T2D), metabolic dysfunction–associated steatotic liver disease (MASLD), and cardiovascular disease (CVD), […]
August 22, 2024
TOPLINE: In patients with type 2 diabetes (T2D) and metabolic dysfunction–associated steatotic liver disease (MASLD), the risk for major liver outcomes appears similar with dipeptidyl peptidase […]
August 21, 2024
A new “best practices” guide released by the Alliance for Pharmacy Compounding (APC) aims to educate compounding pharmacists and reassure prescribers about the ethical, legal, and […]
August 21, 2024
Once-weekly tirzepatide (Zepbound) dramatically reduced the risk of developing type 2 diabetes (T2D) among people with prediabetes and overweight or obesity, Eli Lilly and Co. has […]
August 20, 2024
The allegations against Algerian boxer Imane Khelif at the Paris Olympics raised the questions of intersexuality and its implications in competitive sports. Univadis Italy has decided […]